Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Researchers Make Breakthrough on New Anesthetics

January 20, 2015 12:30 pm | by American Society of Anesthesiologists | News | Comments

For the first time since the 1970s, researchers are on the verge of developing a new class of anesthetics. According to a study published in the February issue of Anesthesiology, the official medical journal of the American Society of Anesthesiologists (ASA), a new approach to identifying compounds may lead to the next generation of anesthetics. Read more...

TOPICS:

New Hope for Restoring Cells in Damaged Brains, Spinal Cords

January 20, 2015 12:26 pm | by Barbara K. Kennedy , Penn State | News | Comments

What motivates Penn State scientists and their students to devote countless hours trying to solve tough research mysteries? For Gong Chen, a biology professor at Penn State, the answer is rooted in a desire to help relieve the suffering of patients and their loved ones. Read more... 

TOPICS:

Article Galaxy Widget: Time-Saving Research Tool

January 20, 2015 12:17 pm | by DeepDyrve | News | Comments

Reprints Desk, Inc., a Research Solutions company and top-rated document delivery supplier, has officially launched its Article Galaxy Widget, a time-saving tool that provides web browser access to scientific, technology and medical (STM) research articles indexed by more than 50 popular search sites and discovery databases, like Google Scholar, PubMed, ResearchGATE, Web of Science and Scopus. Read more...

TOPICS:
Advertisement

Aetna Picks Gilead Sciences Hepatitis C Drugs Over Abbvie's

January 20, 2015 12:01 pm | by Associated Press | News | Comments

Insurer Aetna has made new hepatitis C drugs from Gilead Sciences Inc. preferred treatments for customers with the liver-destroying virus. Read more...                                    

TOPICS:

Eradicating Ebola: What Will It Take?

January 20, 2015 11:23 am | by Ryan Bushey, Associate Editor | Articles | Comments

A lot of work still needs to be done before the Ebola epidemic is finally over. Read more...                             

TOPICS:

Container Closure Integrity: Testing at Low Temps

January 20, 2015 11:10 am | by Louis Brasten, Supervisor, Routine and Functional Analysis/Filling Services, Barbara Jacobs, Scientist, Analytical Services, Alicia Brydzinski, Scientist, Analytical Services - West Pharmaceutical Services, Inc. | Articles | Comments

The container closure integrity, or CCI, on packaging for parenteral drug products plays a critical role in the preservation of the drug product. The combination of the packaging closure components must be carefully selected to eliminate means of contamination that could affect the drug product negatively. Read more...

TOPICS:

Richter, Actavis Announce Phase 3 Results for Schizophrenia Drug Study

January 20, 2015 9:55 am | News | Comments

Gedeon Richter and Actavis announced positive results from a Phase 3 trial evaluating the efficacy and safety of cariprazine. Read more...                    

TOPICS:

'Microcapsules' Have Potential to Repair Osteoarthritis Damage

January 20, 2015 9:44 am | by Queen Mary University of London | News | Comments

A new 'microcapsule' treatment delivery method could reduce inflammation in cartilage affected by osteoarthritis and reverse damage to tissue. Read more...                 

TOPICS:
Advertisement

Immunotherapy Inhibits Heroin Effects in Research Animals

January 20, 2015 9:34 am | by Norwegian Institute of Public Health | News | Comments

Immunotherapy could have a place in the treatment of substance abuse in the future. Read more...                            

TOPICS:

Roche Adds Neuromuscular Disease Research to Portfolio

January 20, 2015 9:18 am | News | Comments

Trophos was working on a drug that could treat spinal muscular atrophy. Read more...                              

TOPICS:

Questions and Answers about Sri Lanka Mystery Kidney Disease

January 20, 2015 9:07 am | by Margie Mason - AP Medical Writer | News | Comments

A mystery kidney disease is killing Sri Lankan farmers. Read more...                                

TOPICS:

AbbVie's New Hepatitis C Treatment Gains European Approval

January 20, 2015 8:44 am | by Linda A. Johnson - AP Business Writer | News | Comments

The company said the European Commission granted marketing authorization for the combination of Viekirax and Exviera. Read more...                      

TOPICS:

Flu News: On the Road to a Universal Vaccine

January 16, 2015 12:13 pm | by Stephanie Guzowski, Editor | Articles | Comments

In early December 2014, the Centers for Disease Control and Prevention (CDC) held a briefing in which the agency announced that the current strain of the virus has mutated, rendering this year’s flu vaccine not as effective. The ideal protective approach against flu is a universal vaccine that targets antigens common to all strains of flu. Read more...

TOPICS:

New Targeted Treatment Strategy for Aggressive Cancers: Study

January 16, 2015 11:42 am | by Mass General Hosp. | News | Comments

Researchers from the Massachusetts General Hospital (MGH) Cancer Center and Boston University School of Medicine (BUSM) have identified the first potential treatment targeting a pathway by which several aggressive tumors maintain their ability to proliferate.

TOPICS:

Mylan Launches Generic Hepatitis B Treatment

January 16, 2015 11:37 am | by Mylan | News | Comments

Mylan Inc. announced the U.S. launch of its Lamivudine Tablets, 100 mg, which is the generic version of GlaxoSmithKline's Epivir-HBV. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading